
    
      Time Perspective: Other: Collection of the baseline data collected at Abatacept IV
      initiation, prospectively or retrospectively within maximum 3 months following the first
      administration. Other assessments are collected during the follow up period (maximum of 2
      years by patient)

      Biospecimen Retention: None Retained excepted for a local sub study (in Spain) where sample
      with DNA was retained
    
  